Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05779> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05779 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05779 label "oglufanide disodium [drugbank:DB05779]" assertion.
- drugbank:DB05779 seeAlso DB05779 assertion.
- drugbank:DB05779 description "Oglufanide disodium is a synthetic dipeptide immunomodulator in development for the treatment of chronic hepatitis C viral infection. Oglufanide disodium was originally developed to treat severe infectious disease in Russia (where it is a registered pharmaceutical), and was extensively studied in cancer clinical trials in the United States before being acquired by Implicit Bioscience in 2005. Oglufanide disodium works as a regulator of the body's immune response, is being given by intranasal administration to patients with chronic hepatitis C viral infection." assertion.
- drugbank:DB05779 identifier "drugbank:DB05779" assertion.
- drugbank:DB05779 title "oglufanide disodium" assertion.
- drugbank:DB05779 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05779 drugbank_vocabulary:drugbank-id "DB05779" assertion.
- drugbank:DB05779 bio2rdf_vocabulary:x-identifiers.org DB05779 assertion.
- drugbank:DB05779 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05779" assertion.
- drugbank:DB05779 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05779 bio2rdf_vocabulary:identifier "DB05779" assertion.